onclive· 2mo ago
save<![CDATA[Ibrutinib Monotherapy Yields Decade-Long Durable Efficacy in Across CLL Subtypes]]>
May 14, 2026read original ↗
<![CDATA[Ibrutinib monotherapy produced durable efficacy over 10 years in patients with or without TP53-mutated chronic lymphocytic leukemia.]]>
The original article is no longer reachable from this URL.
read full article on onclive ↗🔗 mentioned in this article
no entities indexed yet
comments(0)
5-min edit window · permanent after that